Human coronaviruses (HCoVs) cause mild to severe respiratory diseases. Six types of HCoVs
have been discovered, the most recent one termed the Middle East respiratory syndrome …

Objective: To assess the effect of rituximab on the efficacy and safety of influenza virus vaccine
in patients with rheumatoid arthritis (RA). Methods: The study group comprised patients …

Hundreds of immune cell types work in coordination to maintain tissue homeostasis. Upon
infection, dramatic changes occur with the localization, migration, and proliferation of the …

Genetic diversity is the fuel of evolution and facilitates adaptation to novel environments.
However, our understanding of what drives differences in the genetic diversity during the early …

Background Despite the high efficacy of the BNT162b2 messenger RNA vaccine against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), rare breakthrough infections …

Neutralization of Omicron with Third Vaccine Dose Serum samples from 20 participants who
had received two doses of the BNT162b2 vaccine and from 20 who had received three …

A Fourth Dose of mRNA Vaccine in Health Care Workers Health care workers in Israel were
given a fourth dose of BNT162b2 or mRNA-1273 vaccine during a period of omicron-variant …

Background Concurrent with the Pfizer–BioNTech BNT162b2 COVID-19 vaccine roll-out in
Israel initiated on Dec 19, 2020, we assessed the early antibody responses and antibody …

MICA and MICB are stress-induced ligands recognized by the activating receptor NKG2D. A
microRNA encoded by human cytomegalovirus downregulates MICB expression by …

SARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) and other VOCs are spreading in
Europe. Micro-neutralisation assays with sera obtained after Comirnaty (BNT162b2, BioNTech…